No takes yet. Share an insight, caveat, or question.
Laboratory study demonstrates SET9-mediated methylation of the androgen receptor promotes prostate cancer cell growth, highlighting a novel therapeutic target.
Gaughan et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: